SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-05-17 12:55
Tx date 2022-05-13 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights
+16,096 vol 		33,633
Filed 2021-12-28 11:34
Tx date 2021-12-22 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights
+17,537 vol 		17,537
Filed 2021-12-28 11:32
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
Filed 2021-08-26 16:20
Tx date 2021-08-16 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-7,418.0568
-6,153 vol
$1.21 each 		58,500
Filed 2021-08-17 08:31
Tx date 2021-08-17 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-6,153 vol 		26,687
Filed 2021-05-21 12:07
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+7,680 vol 		7,680
Filed 2020-08-21 22:42
Tx date 2020-08-17 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$6,000
+10,000 vol
$0.60 each 		64,653
Filed 2020-05-14 14:07
Tx date 2020-05-13 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+7,000 vol 		32,840
Filed 2019-08-19 15:27
Tx date 2019-08-19 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+7,000 vol 		25,840
Filed 2019-05-25 14:47
Tx date 2019-05-21 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$7,800
+10,000 vol
$0.78 each 		54,653
Filed 2019-05-24 12:07
Tx date 2019-05-21 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$7,800
+10,000 vol
$0.78 each
Filed 2019-05-24 12:07
Tx date 2019-05-21 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$7,800
+10,000 vol
$0.78 each 		54,653
Filed 2019-01-08
Tx date 2019-01-04 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+10,000 vol 		44,653
Filed 2018-05-09
Tx date 2018-05-06 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-2,688 vol 		34,653
Filed 2018-05-07
Tx date 2018-05-06 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-2,688 vol 		18,840
Filed 2018-04-06
Tx date 2018-04-03 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+10,000 vol 		37,341
Filed 2018-03-28
Tx date 2018-03-28 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+7,000 vol 		21,528
Filed 2018-03-16
Tx date 2018-03-13 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights 		$-39,999.10
-75,470 vol
$0.53 each 		0
Filed 2018-03-16
Tx date 2018-03-13 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$19,999
+37,735 vol
$0.53 each 		95,427
Filed 2018-03-16
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-02-16 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights
+75,470 vol 		75,470
Filed 2017-06-28
Tx date 2017-06-28 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+18,500 vol 		27,341
Filed 2017-05-05
Tx date 2017-05-05 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-1,050 vol 		14,528
Filed 2017-05-05
Tx date 2017-05-05 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-1,050 vol 		8,841
Filed 2017-03-08
Tx date 2017-03-07 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+5,687 vol 		15,578
Filed 2016-06-27
Tx date 2016-06-27 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-418 vol 		9,891
Filed 2016-06-27
Tx date 2016-06-27 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-418 vol 		9,891
Filed 2016-03-04
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		10,309
Filed 2016-03-04
Tx date 2016-03-01 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange
+37,313 vol 		57,692
Filed 2016-03-04
Tx date 2016-03-01 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
-37,313 vol 		17,402
Filed 2016-03-04
Tx date 2016-03-01 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
-17,402 vol 		0
Filed 2016-03-04
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		57,692
Filed 2016-02-29
Tx date 2016-02-29 		$NRI
Nuvo Research Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
97 - Other
-3 vol 		10,309
Filed 2016-02-29
Tx date 2016-02-29 		$NRI
Nuvo Research Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
97 - Other
+6 vol 		54,715
Filed 2016-01-06
Tx date 2016-01-01 		$NRI
Nuvo Research Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+3,810 vol 		54,709
Filed 2016-01-04
Tx date 2015-12-31 		$NRI
Nuvo Research Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+1,452 vol 		50,899
Filed 2015-10-01
Tx date 2015-10-01 		$NRI
Nuvo Research Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+1,082 vol 		49,447
Filed 2015-09-24
Tx date 2015-09-21 		$NRI
Nuvo Research Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-9,997
-769 vol
$13.00 each 		10,312
Filed 2015-07-06
Tx date 2015-07-01 		$NRI
Nuvo Research Inc. 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+1,277 vol 		48,365